Skip to Main Content

Paper Details

Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies.
Clin Cancer Res
12
2019
Children, HFSR, PATIENTS, Refractory/Relapsed Leukemia, Skin Toxicities, Solid Tumor Malignancies, Sorafenib, anion-transporting polypeptide 1B1, bevacizumab, bilirubin, children, clofarabine, creatinine, cyclophosphamide, cytarabine, hand-foot skin reaction, leukemia, patients, rash, solid tumor malignancies, sorafenib, sorafenib N-oxide, sorafenib N-oxide and glucuronide, sorafenib glucuronide
Author NameAffiliation
Stanley PoundsSt. Jude Children's Research Hospital
Stanley PoundsSt. Jude Children's Research Hospital
Lie LiDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Aksana VasilyevaCancer Center Administration, St. Jude Children's Research Hospital
Ching-Hon PuiSt. Jude Children's Research Hospital
Ching-Hon PuiUniversity of Tennessee Health Science Center
Ching-Hon PuiSt. Jude Children's Research Hospital
Sharyn D BakerThe Ohio State University
  • 1 - 8

Datasets

Release 1.2